Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.185NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.329NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.229NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.342NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.90NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.169NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.513NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.338NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.284NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.498NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.184NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.187NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
D.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AE.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.110.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.111NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.336NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.400.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.537NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.548NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.24.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.492NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.540NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.487NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AM.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.319NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.182NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.430NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.331NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.112.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.176NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.3.4 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.391NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.393NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.432NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.388NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.48NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.112NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.274NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used